This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Sterigenics International, the leading global provider of contract sterilization, gamma technologies and medical isotopes, today announced expansion at their Forth Worth, Texas location, with the addition of a new gamma cell that will increase capacity by 30%. Expansion will be complete by Q2 2017.
“We have committed more than $80 million in capital investments in the past year to support our customers’ growth strategies,” said Michael Mulhern, CEO of Sterigenics International. “In addition to our Fort Worth expansion, we tripled sterilization capacity at the Sterigenics West Memphis, Arkansas location; significantly expanded our Gurnee, Illinois irradiation facility and increased our global service capabilities with the acquisition of leading Latin American sterilization firm Companhia Brasileira de Esterilização (CBE).”
“The Fort Worth expansion is the direct result of increased regional demand for Sterigenics irradiation services,” said Philip Macnabb, President of Sterigenics International LLC. “We are adding gamma processing capacity of up to 5 million cubic feet per year in Texas, with a product overlap system which will provide the capability to process numerous dose ranges and a wide variety of densities.”
Opened in 1984, Sterigenics Fort Worth provides routine gamma, GammaStat® rapid processing, process validation and SteriPro® laboratory testing.
